BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10430909)

  • 1. A vital role for glycosphingolipid synthesis during development and differentiation.
    Yamashita T; Wada R; Sasaki T; Deng C; Bierfreund U; Sandhoff K; Proia RL
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9142-7. PubMed ID: 10430909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early developmental expression of the gene encoding glucosylceramide synthase, the enzyme controlling the first committed step of glycosphingolipid synthesis.
    Yamashita T; Wada R; Proia RL
    Biochim Biophys Acta; 2002 Dec; 1573(3):236-40. PubMed ID: 12417405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosphingolipid synthesis is essential for MDCK cell differentiation.
    Pescio LG; Favale NO; Márquez MG; Sterin-Speziale NB
    Biochim Biophys Acta; 2012 Jun; 1821(6):884-94. PubMed ID: 22387616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis.
    Jennemann R; Gröne HJ
    Prog Lipid Res; 2013 Apr; 52(2):231-48. PubMed ID: 23473748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosphingolipid synthesis in cerebellar Purkinje neurons: roles in myelin formation and axonal homeostasis.
    Watanabe S; Endo S; Oshima E; Hoshi T; Higashi H; Yamada K; Tohyama K; Yamashita T; Hirabayashi Y
    Glia; 2010 Aug; 58(10):1197-207. PubMed ID: 20544855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylceramide synthase and glycosphingolipid synthesis.
    Ichikawa S; Hirabayashi Y
    Trends Cell Biol; 1998 May; 8(5):198-202. PubMed ID: 9695839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional LoxP-flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis.
    Yamashita T; Allende ML; Kalkofen DN; Werth N; Sandhoff K; Proia RL
    Genesis; 2005 Dec; 43(4):175-80. PubMed ID: 16283624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.
    Jennemann R; Sandhoff R; Wang S; Kiss E; Gretz N; Zuliani C; Martin-Villalba A; Jäger R; Schorle H; Kenzelmann M; Bonrouhi M; Wiegandt H; Gröne HJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12459-64. PubMed ID: 16109770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth].
    Jennemann R; Sandhoff R; Wiegandt H; Gröne HJ
    Verh Dtsch Ges Pathol; 2006; 90():193-202. PubMed ID: 17867597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic glycosphingolipid deficiency and liver function in mice.
    Jennemann R; Rothermel U; Wang S; Sandhoff R; Kaden S; Out R; van Berkel TJ; Aerts JM; Ghauharali K; Sticht C; Gröne HJ
    Hepatology; 2010 May; 51(5):1799-809. PubMed ID: 20432257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and functional characterization of two key enzymes of glycosphingolipid biosynthesis in the amphibian Xenopus laevis.
    Luque ME; Crespo PM; Mónaco ME; Aybar MJ; Daniotti JL; Sánchez SS
    Dev Dyn; 2008 Jan; 237(1):112-23. PubMed ID: 18095347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the synthesis of glycosphingolipid by a ceramide analogue (PPMP) in the gastrulation of Bufo arenarum.
    Aybar MJ; Fuentes A; Sánchez SS
    Zygote; 2000 May; 8(2):159-69. PubMed ID: 10857587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traveling for the glycosphingolipid path.
    Hakomori S
    Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the talin gene arrests mouse development at the gastrulation stage.
    Monkley SJ; Zhou XH; Kinston SJ; Giblett SM; Hemmings L; Priddle H; Brown JE; Pritchard CA; Critchley DR; Fässler R
    Dev Dyn; 2000 Dec; 219(4):560-74. PubMed ID: 11084655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages.
    Liang YJ; Yang BC; Chen JM; Lin YH; Huang CL; Cheng YY; Hsu CY; Khoo KH; Shen CN; Yu J
    Stem Cells; 2011 Dec; 29(12):1995-2004. PubMed ID: 21956927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosphingolipids are essential for intestinal endocytic function.
    Jennemann R; Kaden S; Sandhoff R; Nordström V; Wang S; Volz M; Robine S; Amen N; Rothermel U; Wiegandt H; Gröne HJ
    J Biol Chem; 2012 Sep; 287(39):32598-616. PubMed ID: 22851168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embryo.
    Brigande JV; Platt FM; Seyfried TN
    J Neurochem; 1998 Feb; 70(2):871-82. PubMed ID: 9453585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway.
    Yamanaka S; Zhang XY; Maeda M; Miura K; Wang S; Farese RV; Iwao H; Innerarity TL
    EMBO J; 2000 Oct; 19(20):5533-41. PubMed ID: 11032820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications.
    Ho MY; Yu AL; Yu J
    Glycoconj J; 2017 Dec; 34(6):765-777. PubMed ID: 27549315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases.
    Tifft CJ; Proia RL
    Glycobiology; 2000 Dec; 10(12):1249-58. PubMed ID: 11159916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.